Do Trump tariffs push India Inc to either build in US or pay more?
With fresh tariff threats and mooted carve-outs for firms manufacturing in the US, Indian companies face a choice to either export and absorb duties or invest locally. Past playbooks (JLR, Novelis, KTM, US pharma plants) show it can work when brand, margins, and proximity matter. But higher American costs, policy flip-flops, and uncertain demand argue for selective, long-horizon bets.